IRF1 and hepatocellular carcinoma: Furthermore, both the intrinsic antitumor properties of IRF1 and its ability to influence the formation of the tumor immune microenvironment through the IRF1/CXCL10/CXCR3 axis were demonstrated in hepatocellular carcinoma.